axicabtagene ciloleucel
gilead,daiichi sankyo
['axi-cel', 'lymsm', 'lymphoma']
axi-cel for primary and secondary cns lymphoma - icans 44% (grade 3 in 33%). best orr 78%, cr 67%; at 6 mo, orr 78%. #ash22 #lymsm
Asst. Professor of Medicine, Hematology/Oncology at @PennStHershey, clinical: myeloma #MMSM, lymphoma #lymsm, @Penn alum, @PennStHershey alum. Tweets my own.